September 3rd 2024
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
August 23rd 2024
Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.
Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.
August 22nd 2024
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
August 19th 2024
The First to Know Syphilis Test detects a current or past infection, regardless of successful treatment, in 15 minutes using a drop of blood.
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Phase 3 Trials Launched for AZ SARS-CoV2 Vaccine Candidate
The AstraZeneca-Oxford University investigational coronavirus disease 2019 (COVID-19) vaccine candidate, has expanded into a phase 3 clinical trial.
Upper Respiratory Disorders Symptom Checker: A 5-question Quiz
Some symptoms of COVID-19 overlap with the common cold, flu, and other respiratory diseases. See if you can differentiate between them in these 5 patient scenarios.
NIH COVID-19 Treatment Guidelines Updated Based on New Data
Treatment guidelines on COVID-19 from the NIH were updated today based on data from clinical trials of hydroxychloroquine, ivermectin, and IL-6 inhibitors.
Do Americans Trust Russia’s “Sputnik V” COVID-19 Vaccine?
Approximately 67% of US adults are wary about trusting Russia’s Sputnik V COVID-19 vaccine without proof, according to a new survey of >30 000 Americans.
Poll: Give COVID-19 Vaccine to High-risk Americans First
A Harris Poll finds Americans want a US-approved COVID-19 vaccine allocated here first, the rest of the world next, and our most vulnerable take priority.
FDA Issues EUA for Convalescent Plasma as Potential COVID-19 Treatment
The FDA issued an emergency use authorization for convalescent plasma for the treatment of COVID-19 in hospitalized patients.
5 Questions on CDC Guidance for Catch-up Vaccination during COVID-19
The COVID-19 pandemic makes timely catch-up vaccination against all vaccine-preventable diseases essential. Try these 5 questions on CDC recommendations.
Risk of Death from COVID-19 Among Obese Higher for Men, Younger Adults
Patients with severe obesity are 4-times as likely to die from COVID-19, a new study finds, with younger patients and men with obesity at highest risk.
Adult Pneumococcal Vaccine 2020: 5 Questions on ACIP Update
Pneumococcal vaccine should still be given to adults aged ≥65 years, but no longer to all adults in that population. Find out what you know - and what you may need to know.
ACIP Revises Adult Pneumococcal Vaccination Recommendations: Good, Bad, and Ugly
The ACIP, once more, revised its recommendations for administration of pneumococcal vaccination among adults aged ≥65 years. Is there a lesson learned here?
Beyond Boomers: CDC Urges HCV Screening for All US Adults
HCV is now diagnosed in millennials at about the same rate as in baby boomers; CDC responds with a recommendation for HCV screening in all adults aged ≥18 years.
COVID-19 and Influenza: How Can We Mitigate Certain Calamity?
A pulmonary and critical care specialist identifies 4 factors that will, in part, determine the severity of the 2020-2021 flu season and that can inform preparation.
Remdesivir New Drug Application Submitted to FDA
The investigational antiviral remdesivir in phase 3 clinical trials led to faster time to recovery vs placebo and was found to be safe.
COVID-19 Vaccines: Will Next-gen Platforms Be First?
There are nearly 30 COVID-19 vaccine candidates in human trials. Confused? Here's a short primer on the old and new development platforms and the pros and cons.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 10, 2020
US confirmed cases of COVID-19 surpassed 5 million; global recoveries have exceeded 12 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 5, 2020
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 4, 2020
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of August 3, 2020
US confirmed cases of COVID-19 number nearly 4.6 million; global cases have surpassed 18 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
NIH Updates COVID-19 Treatment Guidance on Corticosteroids, Advance Planning
The National Institutes of Health updated guidance on use of dexamethasone and substitutes in critically ill patients, and on ensuring surrogate decision makers are identified.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of July 31, 2020
US confirmed cases of COVID-19 number nearly 4.5 million; global cases have surpassed 17 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of July 30, 2020
COVID-19 Update: US and Global Cases and Recoveries as of July 28, 2020
Global confirmed cases of COVID-19 are approaching 16.5 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.
Phase 3 Trial of Moderna/NIH COVID-19 Vaccine Candidate is Launched
COVID-19 vaccine hopeful mRNA-1273 will be administered to 30,000 trial volunteers at 89 US research sites.
COVID-19 Update: US and Global Cases and Recoveries as of July 27, 2020
Global confirmed cases of COVID-19 have surpassed 16 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.
Study: After COVID-19, Symptoms Persist for Majority of Patients
JAMA: After recovery from COVID-19, a majority of patients reported persistence of at least 1 symptom; more than half reported ≥3 symptoms.
Survey: More than One-quarter of Parents Hesitant to Vaccinate Children Against Flu
Parental doubts about efficacy drive flu-shot hesitancy, according to a new survey, and impact routine vaccination rates, as well.
FDA Issues EUA for Combined Influenza-COVID-19 Diagnostic
The EUA is the third for diagnostics designed for detection and differentiation of the viruses that cause COVID-19 and the flu.
Scientists Appeal to WHO to Recognize COVID-19 Airborne Transmission Threat
A letter to the World Health Organization signed by more than 200 scientists from around the world strongly urges the agency to acknowledge airborne transmission of the SARS-Cov2 virus.
NIH: Dexamethasone Recommendations for Patients with COVID-19
The NIH COVID-19 Treatment Guidelines Panel published guidelines on use of the corticosteroid dexamethasone in patients severely ill with COVID-19.
511 Epidemiologists Weigh In on Resuming 20 Everyday Activities
The New York Times asked 511 epidemiologists when they might resume hair cuts, shaking hands, air travel, bus rides, and 15 other "normal" activities suspended during COVID-19 social distancing.